Bruce W. Carter Veterans Affairs Medical Center ( Site 0082) — Miami, Florida

Bruce W. Carter Veterans Affairs Medical Center ( Site 0082) is a clinical research site located in Miami, Florida, United States 33125.

Crixeo Clinical Trials Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.

Bruce W. Carter Veterans Affairs Medical Center ( Site 0082) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Prostate Cancer Metastatic.

Sponsors: Merck Sharp & Dohme LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Miami

Browse all research sites in Florida · View every site in Miami

Sponsor Feasibility Report

Trust Score: 84/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Bruce W. Carter Veterans Affairs Medical Center ( Site 0082)?

Bruce W. Carter Veterans Affairs Medical Center ( Site 0082) has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Bruce W. Carter Veterans Affairs Medical Center ( Site 0082) conducted?

Bruce W. Carter Veterans Affairs Medical Center ( Site 0082) has 1 clinical trials on record, with 1 currently active. Their work covers Prostate Cancer Metastatic.

Is Bruce W. Carter Veterans Affairs Medical Center ( Site 0082) accredited by Crixeo Clinical Trials?

Bruce W. Carter Veterans Affairs Medical Center ( Site 0082) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Bruce W. Carter Veterans Affairs Medical Center ( Site 0082)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.